ACLARIS THERAPEUTICS INC (ACRS) Stock Cash Flow
NASDAQ:ACRS - Nasdaq - US00461U1051 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -130.21M | -132.06M | -88.48M | -86.91M | -90.87M | |||
| Depreciation Amortization | 692.00K | 807.00K | 863.00K | 800.00K | 920.00K | |||
| Income Taxes - Deferred | N/A | N/A | -367.00K | N/A | 0.00 | |||
| Change In Working Capital | 17.99M | 10.92M | 9.39M | -1.20M | -1.34M | |||
| Other non cash items | 99.21M | 100.26M | 271.00K | 19.74M | 39.15M | |||
| OPERATING CASH FLOW | -12.32M | -20.07M | -78.33M | -67.57M | -52.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -36.67M | -35.93M | -1.31M | -610.00K | -310.00K | |||
| Other Investing Activity | -30.81M | -33.84M | 47.53M | 13.23M | -167.32M | |||
| INVESTING CASH FLOW | -67.48M | -69.77M | 46.22M | 12.63M | -167.63M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | -11.48M | |||
| Stock Issued/Repurchased | N/A | 74.94M | 26.81M | 72.90M | 239.66M | |||
| Other Financing Activity | -629.00K | -409.00K | -102.00K | -30.00K | -3.12M | |||
| FINANCING CASH FLOW | 74.32M | 74.54M | 26.71M | 72.87M | 225.05M | |||
| CHANGE IN CASH | -5.48M | -15.31M | -5.40M | 17.93M | 5.29M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.32M | -20.07M | -78.33M | -67.57M | -52.13M | |||
| Capital Expenditure | -36.67M | -35.93M | -1.31M | -610.00K | -310.00K | |||
| FREE CASH FLOW | -48.99M | -56.01M | -79.63M | -68.18M | -52.44M | |||
All data in USD